Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: Results of a multicentre prospective study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 3, 2009, Pages 354-361

  Chatterton, B E ^a   Ho Shon, I ^b   Baldey, A ^c   Lenzo, N ^d   Patrikeos, A ^d   Kelley, B ^e   Wong, D ^e   Ramshaw, J E ^f   Scott, A M ^g  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e WESLEY HOSPITAL   (Australia)

^f Australian and New Zealand Association of Physicians in Nuclear Medicine   (Australia)

^g AUSTIN HOSPITAL   (Australia)

Author keywords

18F FDG PET; Oesophageal cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ESOPHAGUS CANCER; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; SURVIVAL TIME;

AGED; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60549111970     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0959-y     Document Type: Article

References (31)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66
2. PR Pfau SB Perlman P Stanko TJ Frick DV Gopal A Said 2007 The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography Gastrointest Endosc 65 377 84
3. JM Omloo GW Sloof R Boellaard OS Hoekstra PL Jager HM van Dullemen 2008 Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer Endoscopy 40 464 71
4. LF Wu BZ Wang JL Feng WR Cheng GR Liu XH Xu 2003 Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI World J Gastroenterol 9 219 24
5. WA Weber SI Ziegler R Thödtmann AR Hanauske M Schwaiger 1999 Reproducibility of metabolic measurements in malignant tumors using FDG PET J Nucl Med 40 1771 77
6. HL van Westreenen M Westerterp PM Bossuyt J Pruim GW Sloof JJ van Lanschot 2004 Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer J Clin Oncol 22 3805 3812
7. WL Wong RJ Chambers 2008 Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review Abdom Imaging 33 183 90
8. YC Yoon KS Lee YM Shim BT Kim K Kim TS Kim 2003 Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study Radiology 227 764 70
9. PA Heeren PL Jager F Bongaerts H van Dullemen W Sluiter JT Plukker 2004 Detection of distant metastases in esophageal cancer with (18)F-FDG PET J Nucl Med 45 980 87
10. EI Sihvo JV Rasanen MJ Knuuti HR Minn ME Luostarinen T Viljanen 2004 Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease J Gastrointest Surg 8 988 96
11. R Bar-Shalom L Guralnik M Tsalic M Leiderman A Frenkel D Gaitini 2005 The additional value of PET/CT over PET in FDG imaging of oesophageal cancer Eur J Nucl Med Mol Imaging 32 918 24
12. JF Bruzzi MT Truong H Macapinlac RF Munden JJ Erasmus 2007 Integrated CT-PET imaging of esophageal cancer: unexpected and unusual distribution of distant organ metastases Curr Probl Diagn Radiol 36 21 9
13. H Jadvar RW Henderson PS Conti 2006 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography imaging evaluation of esophageal cancer Mol Imaging Biol 8 193 200
14. T Leong C Everitt K Yuen S Condron A Hui SY Ngan 2006 A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer Radiother Oncol 78 254 61
15. CP Duong H Demitriou L Weih A Thompson D Williams RJ Thomas 2006 Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer Eur J Nucl Med Mol Imaging 33 759 69
16. A Imdahl M Hentschel M Kleimaier UT Hopt I Brink 2004 Impact of FDG-PET for staging of oesophageal cancer Langenbecks Arch Surg 389 283 88
17. HL van Westreenen PA Heeren HM van Dullemen EJ van der Jagt PL Jager H Groen 2005 Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations J Gastrointest Surg 9 54 61
18. BF Meyers RJ Downey PA Decker RJ Keenan BA Siegel RJ Cerfolio 2007 The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial J Thorac Cardiovasc Surg 133 738 45
19. S Gananadha EJ Hazebroek S Leibman H Berry L Osgood I Ho Shon 2008 The utility of FDG-PET in the preoperative staging of esophageal cancer Dis Esophagus 21 389 94
20. A Stahl J Stollfuss K Ott H Wieder U Fink M Schwaiger 2005 FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding Nuklearmedizin 44 249 55
21. HL van Westreenen JT Plukker DC Cobben CJ Verhoogt H Groen PL Jager 2005 Prognostic value of the standardized uptake value in esophageal cancer AJR Am J Roentgenol 185 436 40
22. AW Blackstock MR Farmer J Lovato G Mishra SA Melin T Oaks 2006 A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer Int J Radiat Oncol Biol Phys 64 455 60
23. JY Choi HJ Jang YM Shim K Kim KS Lee KH Lee 2004 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications J Nucl Med 45 1843 50
24. D Hong S Lunagomez EE Kim JH Lee RS Bresalier SG Swisher 2005 Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma Cancer 104 1620 26
25. H Kato T Miyazaki M Nakajima J Takita H Kimura A Faried 2005 The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma Cancer 103 148 56
26. W Kneist M Schreckenberger P Bartenstein C Menzel K Oberholzer T Junginger 2004 Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma Arch Surg 139 1043 49
27. G Liberale JL Van Laethem F Gay S Goldman N Nagy E Coppens 2004 The role of PET scan in the preoperative management of oesophageal cancer Eur J Surg Oncol 30 942 947
28. V Malik M Keogan C Gilham G Duffy N Ravi JV Reynolds 2006 FDG-PET scanning in the management of cancer of the oesophagus and oesophagogastric junction: early experience with 100 consecutive cases Ir J Med Sci 175 48 54
29. CC Rest JP Metges P Teyton VJ Tallec P Lozac'h A Volant 2008 Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study Nucl Med Commun 29 628 35
30. RJ Cerfolio AS Bryant 2006 Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival Ann Thorac Surg 82 391 94
31. N Rizk RJ Downey T Akhurst M Gonen MS Bains S Larson 2006 Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection Ann Thorac Surg 81 1076 81